Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Lymphoma, Non-Hodgkin 1Leukemia 1

Interventions

Gemcitabine 4Oxaliplatin 3Early Intervention, Educational 3Cisplatin 3Paclitaxel 2Cyclophosphamide 2Vinorelbine 1Soybean Proteins 1Semaxinib 1Restraint, Physical 1Platelet Aggregation 1Muromonab-CD3 1Mental Status and Dementia Tests 1Irinotecan 1Interferon-alpha 1Immunization, Passive 1Granisetron 1Fenretinide 1Doxorubicin 1Diet Therapy 1Diathermy 1Counseling 1Carboplatin 1CP 609754 1Bleeding Time 1Biological Therapy 1Bevacizumab 1BMS188797 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Unspecified Adult Solid Tumor, Protocol Specific × Immunization, Passive × Clear all
NCT00002482 2013-11-06

Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡